Another way by which HSF1 helps tumor cells to evade immune surveillance is by suppressing the expression of CCL5, a CD8+ T-cell chemokine, thereby inhibiting the recruitment and infiltration of CD8+ T-cells into the tumor microenvironment [21]. The gene discussed is TBXT; the disease is neoplasm.